CA Patent

CA2696613C — Compositions and methods for modulating endophthalmitis using fluoroquinolones

Assigned to Bausch and Lomb Inc · Expires 2012-09-18 · 14y expired

What this patent protects

Compositions for modulating endophthalmitis comprise a fluoroquinolone having one of Formulae I- VIII. Methods for modulating endophthalmitis comprise administering such compositions to a subject in need thereof. The compositions and methods are suitable for modulating post-opera…

USPTO Abstract

Compositions for modulating endophthalmitis comprise a fluoroquinolone having one of Formulae I- VIII. Methods for modulating endophthalmitis comprise administering such compositions to a subject in need thereof. The compositions and methods are suitable for modulating post-operative endophthalmitis, post-traumatic endophthalmitis, non-infectious endophthalmitis, panophthalmitis, hematogenous endophthalmitis, or combinations thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA2696613C
Jurisdiction
CA
Classification
—
Expires
2012-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Bausch and Lomb Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.